Nagase & Co (NGSCF) Fair Value & Analysis

Basic Materials · US · Market cap $3.0B

Below-average quality, and screening another 12% overvalued on our models.

What matters now

• A fairly wide model range ($4.65 to $9.99) leaves room in how you read the outcome.
• Our model range runs from $4.65 (bear) to $9.99 (bull), base $6.49. The closer the price sits to the lower half, the larger the margin of safety.
• Quality 41/100 (below-average quality) with high evidence: the data supports the verdict.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 19, 2026.

How to read this chart

60‑month range $2.26 – $781,940 · fair‑value band $4.65 – $9.99 · the $7.36 price screens above the $6.49 fair value. Dashed = 300-day average. As of Jul 19, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Nagase & Co (NGSCF) currently trades at $7.36, while our model-based Fair Value estimate is $6.49, implying the stock looks roughly 11.8% overvalued today. The Quality Score stands at 41/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Nagase & Co generated revenue of $973B at a net margin of 3.4%. Revenue grew 9.6% year over year. It earns a return on equity of 8.1%. Net debt stands at $127B. Fundamentals as of Jul 19, 2026

Our scenario range runs from $4.65 (bear case) to $9.99 (bull case); at $7.36, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -12%, NGSCF screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Multiples ($9.04) versus Growth DCF ($3.99). Highest evidence: Growth DCF (80).

Key figures & financial health

Quality Score breakdown

About the company

Nagase & Co., Ltd. manufactures, imports/exports, and sells chemicals, plastics, electronics materials, cosmetics, and health foods worldwide.

Full company description

Nagase & Co., Ltd. manufactures, imports/exports, and sells chemicals, plastics, electronics materials, cosmetics, and health foods worldwide. It offers paints/inks, dyestuffs, pigments, additives, thermal paper materials, toner, inkjet materials, adhesives, urethane materials, plastic and other auxiliary materials, industrial oil solutions, water processing raw materials, fluorochemicals, silicone materials, environmental solutions, metal filters, coatings, urethane foam, synthesis, electronics chemicals, digital print processing materials, communications equipment, metal processing, stationery, functional film and sheet, and hygiene materials. It also provides thermoplastic and thermosetting resins, resin molding tools/dies, and products for office equipment, home appliances, electrical equipment, mobile communications, games, packaging, and construction materials. The company offers epoxy resins, fluorine products, precision abrasives, semiconductor assembly materials and devices, display panel components and devices, chemical management equipment, vacuum equipment, liquid state analysis equipment, LEDs, 3D printing products, solar panels, and electronic component materials for AR/VR, electrical, HDD, automotive and aircraft, display, touch panels, housing, lighting, renewable energy, and commercial facilities. It provides plastic products for secondary batteries, electrification, sensor components, in-vehicle electronics products, in-vehicle display-related components, and other related products. The company offers pharmaceutical materials, research products, diagnostic reagents, food ingredients and additives, sports nutrition products, nutrient premixes, cosmetic materials and additives, and agricultural, fisheries, and other materials to the pharmaceutical, food and beverage, cosmetics, agricultural, toiletries, health care, and other industries. The company was founded in 1832 and is headquartered in Osaka, Japan.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Nagase & Co reported revenue of $973B in FY2026 versus $781B in FY2022, a compound +5.7%/yr. Reported net income was $33.1B in FY2026, compounding +6.3%/yr from FY2022.

NGSCF screens 12% overvalued. Compare with Linde plc →

Peer Group

Specialty Chemicals · 676 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).

Explore undervalued stocks

More undervalued Basic Materials stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.